1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Epigenetic Market Size Growth Rate by Type (2022-2028) 1.2.2 Reagents 1.2.3 Kits 1.2.4 Instruments 1.2.5 Enzymes 1.2.6 Services 1.3 Market by Application 1.3.1 Global Epigenetic Market Share by Application (2022-2028) 1.3.2 Academic Research Institutes 1.3.3 Biotechnology Companies 1.3.4 Biopharmaceutical Companies 1.3.5 Diagnostic Companies 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Epigenetic Market Size 2.2 Epigenetic Market Size by Regions 2.2.1 Epigenetic Growth Rate by Regions (2022-2028) 2.2.2 Epigenetic Market Share by Regions (2022-2028) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 Epigenetic Revenue by Players (2022 & 2028) 3.2 Epigenetic Key Players Headquarters and Area Served 3.3 Key Players Epigenetic Product/Solution/Service 3.4 Date of Enter into Epigenetic Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global Epigenetic Market Size by Type (2022-2028) 4.2 Global Epigenetic Market Size by Application (2022-2028) 5 North America 5.1 North America Epigenetic Market Forecast (2022-2028) 5.2 Epigenetic Key Players in North America 5.3 North America Epigenetic Market Size by Type 5.4 North America Epigenetic Market Size by Application 6 Europe 6.1 Europe Epigenetic Market Forecast (2022-2028) 6.2 Epigenetic Key Players in Europe 6.3 Europe Epigenetic Market Size by Type 6.4 Europe Epigenetic Market Size by Application 7 Asia-Pacific 7.1 Asia-Pacific Epigenetic Market Forecast (2022-2028) 7.2 Epigenetic Key Players in Asia-Pacific 7.3 Asia-Pacific Epigenetic Market Size by Type 7.4 Asia-Pacific Epigenetic Market Size by Application 8 Rest of World 8.1 Latin America 8.1.1 Latin America Epigenetic Market Analysis 8.1.2 Key Players in Latin America 8.2 Middle East & Africa 8.2.1 Middle East & Africa Epigenetic Market Analysis 8.2.2 Key Players in Middle East & Africa 9 International Player Profiles 9.1 Illumina 9.1.1 Illumina Company Details 9.1.2 Illumina Description and Business Overview 9.1.3 Illumina Epigenetic Introduction 9.1.4 Illumina Revenue in Epigenetic Business (2022 & 2028) 9.1.5 Illumina Recent Development 9.2 Qiagen 9.2.1 Qiagen Company Details 9.2.2 Qiagen Description and Business Overview 9.2.3 Qiagen Epigenetic Introduction 9.2.4 Qiagen Revenue in Epigenetic Business (2022 & 2028) 9.2.5 Qiagen Recent Development 9.3 Abcam 9.3.1 Abcam Company Details 9.3.2 Abcam Description and Business Overview 9.3.3 Abcam Epigenetic Introduction 9.3.4 Abcam Revenue in Epigenetic Business (2022 & 2028) 9.3.5 Abcam Recent Development 9.4 Merck & Co 9.4.1 Merck & Co Company Details 9.4.2 Merck & Co Description and Business Overview 9.4.3 Merck & Co Epigenetic Introduction 9.4.4 Merck & Co Revenue in Epigenetic Business (2022 & 2028) 9.4.5 Merck & Co Recent Development 9.5 Sigma-Aldrich 9.5.1 Sigma-Aldrich Company Details 9.5.2 Sigma-Aldrich Description and Business Overview 9.5.3 Sigma-Aldrich Epigenetic Introduction 9.5.4 Sigma-Aldrich Revenue in Epigenetic Business (2022 & 2028) 9.5.5 Sigma-Aldrich Recent Development 9.6 New England Biolabs 9.6.1 New England Biolabs Company Details 9.6.2 New England Biolabs Description and Business Overview 9.6.3 New England Biolabs Epigenetic Introduction 9.6.4 New England Biolabs Revenue in Epigenetic Business (2022 & 2028) 9.6.5 New England Biolabs Recent Development 9.7 Thermo Fisher Scientific 9.7.1 Thermo Fisher Scientific Company Details 9.7.2 Thermo Fisher Scientific Description and Business Overview 9.7.3 Thermo Fisher Scientific Epigenetic Introduction 9.7.4 Thermo Fisher Scientific Revenue in Epigenetic Business (2022 & 2028) 9.7.5 Thermo Fisher Scientific Recent Development 9.8 Diagenode 9.8.1 Diagenode Company Details 9.8.2 Diagenode Description and Business Overview 9.8.3 Diagenode Epigenetic Introduction 9.8.4 Diagenode Revenue in Epigenetic Business (2022 & 2028) 9.8.5 Diagenode Recent Development 9.9 Active Motif 9.9.1 Active Motif Company Details 9.9.2 Active Motif Description and Business Overview 9.9.3 Active Motif Epigenetic Introduction 9.9.4 Active Motif Revenue in Epigenetic Business (2022 & 2028) 9.9.5 Active Motif Recent Development 9.10 Roche Diagnostics 9.10.1 Roche Diagnostics Company Details 9.10.2 Roche Diagnostics Description and Business Overview 9.10.3 Roche Diagnostics Epigenetic Introduction 9.10.4 Roche Diagnostics Revenue in Epigenetic Business (2022 & 2028) 9.10.5 Roche Diagnostics Recent Development 9.11 Eisai 9.11.1 Eisai Company Details 9.11.2 Eisai Description and Business Overview 9.11.3 Eisai Epigenetic Introduction 9.11.4 Eisai Revenue in Epigenetic Business (2022 & 2028) 9.11.5 Eisai Recent Development 9.12 Novartis 9.12.1 Novartis Company Details 9.12.2 Novartis Description and Business Overview 9.12.3 Novartis Epigenetic Introduction 9.12.4 Novartis Revenue in Epigenetic Business (2022 & 2028) 9.12.5 Novartis Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details

List of Tables Table 1. Global Epigenetic Market Size Growth Rate by Type (2022-2028) (US$ Million) Table 2. Key Players of Reagents Table 3. Key Players of Kits Table 4. Key Players of Instruments Table 5. Key Players of Enzymes Table 6. Key Players of Services Table 7. Global Epigenetic Market Size Growth by Application (2022-2028) (US$ Million) Table 8. Global Epigenetic Market Size by Regions (2022-2028) (US$ Million) Table 9. Global Epigenetic Market Share by Regions (2022-2028) Table 10. Market Top Trends Table 11. Market Use Cases Table 12. Global Epigenetic Revenue by Players (2022 & 2028) (US$ Million) Table 13. Global Epigenetic Market Share by Players (2022 &2028) Table 14. Key Players Headquarters and Area Served Table 15. Key Players Epigenetic Product/Solution/Service Table 16. Date of Enter into Epigenetic Market Table 17. Mergers & Acquisitions, Expansion Plans Table 18. Global Epigenetic Market Size by Type (2022-2028) (US$ Million) Table 19. Global Epigenetic Market Size Share by Type (2022-2028) Table 20. Global Epigenetic Market Size by Application (2022-2028) (US$ Million) Table 21. Global Epigenetic Market Size Share by Application (2022-2028) Table 22. North America Key Players Epigenetic Revenue (2022 & 2028) & (US$ Million) Table 23. North America Key Players Epigenetic Market Share (2022 & 2028) Table 24. North America Epigenetic Market Size by Type (2022-2028) (US$ Million) Table 25. North America Epigenetic Market Share by Type (2022-2028) Table 26. North America Epigenetic Market Size by Application (2022-2028) (US$ Million) Table 27. North America Epigenetic Market Share by Application (2022-2028) Table 28. Europe Key Players Epigenetic Revenue (2022 & 2028) & (US$ Million) Table 29. Europe Key Players Epigenetic Market Share (2022 & 2028) Table 30. Europe Epigenetic Market Size by Type (2022-2028) (US$ Million) Table 31. Europe Epigenetic Market Share by Type (2022-2028) Table 32. Europe Epigenetic Market Size by Application (2022-2028) (US$ Million) Table 33. Europe Epigenetic Market Share by Application (2022-2028) Table 34. Asia-Pacific Key Players Epigenetic Revenue (2022 & 2028) & (US$ Million) Table 35. Asia-Pacific Key Players Epigenetic Market Share (2022 & 2028) Table 36. Asia-Pacific Epigenetic Market Size by Type (2022-2028) (US$ Million) Table 37. Asia-Pacific Epigenetic Market Share by Type (2022-2028) Table 38. Asia-Pacific Epigenetic Market Size by Application (2022-2028) (US$ Million) Table 39. Asia-Pacific Epigenetic Market Share by Application (2022-2028) Table 40. Key Players in Latin America Table 41. Key Players in Middle East & Africa Table 42. Illumina Company Details Table 43. Illumina Description and Business Overview Table 44. Illumina Epigenetic Product Table 45. Illumina Revenue in Epigenetic Business 2022 & 2028 Table 46. Illumina Recent Development Table 47. Qiagen Company Details Table 48. Qiagen Description and Business Overview Table 49. Qiagen Epigenetic Product Table 50. Qiagen Revenue in Epigenetic Business 2022 & 2028 Table 51. Qiagen Recent Development Table 52. Abcam Company Details Table 53. Abcam Description and Business Overview Table 54. Abcam Epigenetic Product Table 55. Abcam Revenue in Epigenetic Business 2022 & 2028 Table 56. Abcam Recent Development Table 57. Merck & Co Company Details Table 58. Merck & Co Description and Business Overview Table 59. Merck & Co Epigenetic Product Table 60. Merck & Co Revenue in Epigenetic Business 2022 & 2028 Table 61. Merck & Co Recent Development Table 62. Sigma-Aldrich Company Details Table 63. Sigma-Aldrich Description and Business Overview Table 64. Sigma-Aldrich Epigenetic Product Table 65. Sigma-Aldrich Revenue in Epigenetic Business 2022 & 2028 Table 66. Sigma-Aldrich Recent Development Table 67. New England Biolabs Company Details Table 68. New England Biolabs Description and Business Overview Table 69. New England Biolabs Epigenetic Product Table 70. New England Biolabs Revenue in Epigenetic Business 2022 & 2028 Table 71. New England Biolabs Recent Development Table 72. Thermo Fisher Scientific Company Details Table 73. Thermo Fisher Scientific Description and Business Overview Table 74. Thermo Fisher Scientific Epigenetic Product Table 75. Thermo Fisher Scientific Revenue in Epigenetic Business 2022 & 2028 Table 76. Thermo Fisher Scientific Recent Development Table 77. Diagenode Company Details Table 78. Diagenode Description and Business Overview Table 79. Diagenode Epigenetic Product Table 80. Diagenode Revenue in Epigenetic Business 2022 & 2028 Table 81. Diagenode Recent Development Table 82. Active Motif Company Details Table 83. Active Motif Description and Business Overview Table 84. Active Motif Epigenetic Product Table 85. Active Motif Revenue in Epigenetic Business 2022 & 2028 Table 86. Active Motif Recent Development Table 87. Roche Diagnostics Company Details Table 88. Roche Diagnostics Description and Business Overview Table 89. Roche Diagnostics Epigenetic Product Table 90. Roche Diagnostics Revenue in Epigenetic Business 2022 & 2028 Table 91. Roche Diagnostics Recent Development Table 92. Eisai Company Details Table 93. Eisai Description and Business Overview Table 94. Eisai Epigenetic Product Table 95. Eisai Revenue in Epigenetic Business 2022 & 2028 Table 96. Eisai Recent Development Table 97. Novartis Company Details Table 98. Novartis Description and Business Overview Table 99. Novartis Epigenetic Product Table 100. Novartis Revenue in Epigenetic Business 2022 & 2028 Table 101. Novartis Recent Development Table 102. Epigenetic Market Trends Table 103. Epigenetic Market Drivers Table 104. Epigenetic Market Challenges Table 105. Epigenetic Market Restraints Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Global Epigenetic Market Share by Type in 2022 & 2028 Figure 2. Reagents Features Figure 3. Kits Features Figure 4. Instruments Features Figure 5. Enzymes Features Figure 6. Services Features Figure 7. Global Epigenetic Market Share by Application in 2022 & 2028 Figure 8. Academic Research Institutes Case Studies Figure 9. Biotechnology Companies Case Studies Figure 10. Biopharmaceutical Companies Case Studies Figure 11. Diagnostic Companies Case Studies Figure 12. Epigenetic Report Years Considered Figure 13. Global Epigenetic Market Size and Growth Rate (2022-2028) (US$ Million) Figure 14. Global Epigenetic Market Share by Regions (2022-2028) Figure 15. Global Epigenetic Market Share by Players in 2021 Figure 16. Global Epigenetic Market Size Market Share by Type (2022-2028) Figure 17. Global Epigenetic Market Size Market Share by Application (2022-2028) Figure 18. Global Epigenetic Revenue Market Share by Application in 2021 Figure 19. North America Epigenetic Market Size 2022-2028 (US$ Million) Figure 20. Europe Epigenetic Market Size 2022-2028 (US$ Million) Figure 21. Asia-Pacific Epigenetic Market Size 2022-2028 (US$ Million) Figure 22. Epigenetic Market Size in Latin America (2022-2028) (US$ Million) Figure 23. Epigenetic Market Size in Middle East & Africa (2022-2028) (US$ Million) Figure 24. Bottom-up and Top-down Approaches for This Report Figure 25. Data Triangulation Figure 26. Key Executives Interviewed

Reagents Kits Instruments Enzymes Services